Ticker

Neuroscience imaging company IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has presented new research at a European conference this week showing one MRI technique provides better contrast than another when imaging a brain region linked to Parkinson's disease. The study compared two magnetic resonance imaging (MRI) methods, magnetisation transfer gradient echo (MT-GRE) and turbo spin echo (TSE), for visualising the…

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after...

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after two clients discontinued Huntington's disease programmes it was supporting. The AIM-listed company said the cancellations would reduce its contracted order book by around £1.5 million over the next two financial years.

South32 Ltd (LSE:S32, ASX:S32, FRA:32Z, OTC:SHTLF, JSE:S32) has secured a major US federal approval for its US$4.7 billion Hermosa critical minerals project...

Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, rose 11% to 9p after it has raised its revenue forecast for the...